Had You Invested $1,000 in Altria or Philip Morris 10 Years Ago, Here’s What You’d Have Now

A decade ago, Altria Group (NYSE: MO) and Philip Morris International (NYSE: PM) faced the same existential question: what happens to a tobacco company when fewer people smoke? Their answers diverged sharply.

Altria stayed focused on the U.S. market, leaning on Marlboro’s pricing power while building a smoke-free portfolio through NJOY, the on! nicotine pouch brand, and a heated tobacco joint venture. Philip Morris went global and moved aggressively into smoke-free products, acquiring Swedish Match (home of ZYN nicotine pouches) and scaling IQOS across international markets. Both faced structural cigarette volume declines but offset them through pricing, new categories, and dividend growth.

For long-term investors, the story isn’t really about share price. It’s about income compounding quietly for a decade.

Price Alone Understates the Picture

Altria — Price Return Only

• Initial Investment: $1,000
• Current Value (price only): $2,051 (+105.06%)
• S&P 500 (same period): $3,236 (+223.63%)

Philip Morris — Price Return Only

• Initial Investment: $1,000
• Current Value (price only): $2,792 (+179.24%)
• S&P 500 (same period): $3,236 (+223.63%)

On price alone, both stocks trailed the S&P 500 over 10 years. But these are among the most dividend-intensive stocks in the market, and stripping out income misrepresents what investors actually earned. Dividends substantially change the investment outcome for both stocks over this horizon. Altria’s quarterly dividend grew from roughly $0.565 per quarter in early 2016 to $1.06 today, nearly doubling. Philip Morris went from $1.02 per quarter in early 2016 to $1.47 by late 2025. Reinvesting those payments over 10 years adds substantial value that the price chart does not show.

The one-year picture is more favorable. Altria stock gained 13.3% over the past year, versus the S&P 500’s 17.5% rise. Philip Morris gained 5.6% over the same stretch, trailing the index. Over five years, Altria returned 29.7% on price, trailing the S&P 500’s 68.7% gain, while PM’s 82.5% was the standout figure across both names.

Comparing the Two Today

Philip Morris trades at a forward P/E of roughly 20x, which isn’t cheap, but analysts have a consensus target of $194.84 against a current price of around $163, implying meaningful upside. The 3.5% dividend yield adds income on top. Smoke-free products like IQOS and ZYN have been gaining global share, though regulatory tightening on nicotine pouches, IQOS market access restrictions in key geographies, and currency headwinds remain factors for a company with nearly all revenue outside the United States.

Altria offers a higher yield at roughly 6.5%, with a forward P/E near 12x, but ongoing domestic cigarette volume declines and an ongoing CEO transition are factors analysts are watching.